Citigroup’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Citigroup’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,482	Closed	-$17K	–	5775
2026 Q1	$17K	Buy	+5,482	New	+$22.7K	﹤0.01%	4875
2025 Q1	–	Sell	-28	Closed	-$899	–	5616
2024 Q4	$899	Hold	28	–	–	﹤0.01%	5602
2024 Q3	$1.11K	Hold	28	–	–	﹤0.01%	5443
2024 Q2	$1.43K	Hold	28	–	–	﹤0.01%	5358
2024 Q1	$1.23K	Hold	28	–	–	﹤0.01%	5423
2023 Q4	$1.22K	Hold	28	–	–	﹤0.01%	5457
2023 Q3	$1.47K	Hold	28	–	–	﹤0.01%	5031
2023 Q2	$1.7K	Hold	28	–	–	﹤0.01%	5306
2023 Q1	$1.27K	Hold	28	–	–	﹤0.01%	5139
2022 Q4	$3.39K	Hold	28	–	–	﹤0.01%	5115
2022 Q3	$4K	Hold	28	–	–	﹤0.01%	5284
2022 Q2	$5K	Hold	28	–	–	﹤0.01%	5598
2022 Q1	$7K	Hold	28	–	–	﹤0.01%	5675
2021 Q4	$7K	Hold	28	–	–	﹤0.01%	5619
2021 Q3	$9K	Hold	28	–	–	﹤0.01%	5489
2021 Q2	$13K	Hold	28	–	–	﹤0.01%	5527
2021 Q1	$14K	Buy	+28	New	+$12.2K	﹤0.01%	5432
2016 Q2	–	Hold	0	–	–	–	7093
2016 Q1	–	Hold	0	–	–	–	7471
2015 Q4	–	Sell	-1	Closed	-$16K	–	7573
2015 Q3	$16K	Buy	+1	New	+$6.71K	﹤0.01%	6169
2015 Q2	–	Hold	0	–	–	–	7530
2015 Q1	–	Hold	0	–	–	–	7030
2014 Q4	–	Hold	0	–	–	–	6845
2014 Q2	–	Hold	0	–	-$2K	–	7120
2014 Q1	–	Hold	0	–	–	–	6769

Other funds holding CANF

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup's CANF Position: Q2 2026 in Review

Citigroup sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2026, closing a stake of 5,482 shares — an estimated $17K sold.

Citigroup first reported a position in CANF in Q3 2015 and held it in 18 quarters. The position peaked at $17K in Q1 2026. 8 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

Citigroup reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Citigroup sold 5,482 Can-Fite BioPharma American Depositary Shares shares in Q2 2026, an estimated $17K.
Citigroup first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2015 and held it in 18 quarters.
Citigroup's Can-Fite BioPharma American Depositary Shares position peaked at $17K in Q1 2026.
8 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.